|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 224.44 USD | +1.45% |
|
-1.87% | -6.79% |
| 04-15 | Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating | MT |
| 04-13 | Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 32.09B | |||||
| 195B | |||||
| 160B | |||||
| 138B | |||||
| 88.46B | |||||
| 49.91B |
- Stock Market
- Equities
- RMD Stock
- Charts ResMed, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition